Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Greenberger

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Oncology Research|January 1, 1994
P-glycoprotein mediates profound resistance to bisantreneX P Zhang, M K Ritke, J C Yalowich, et al.
Blood Cancer Discovery|September 8, 2022
Anti-spike T-cell and Antibody Responses to SARS-CoV-2 mRNA Vaccines in Patients with Hematologic MalignanciesLee M Greenberger, Larry A Saltzman, Lore M Gruenbaum, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2008
A novel 5-[1,3,4-oxadiazol-2-yl]-N-aryl-4,6-pyrimidine diamine having dual EGFR/HER2 kinase activity: design, synthesis, and biological activityTerry V Hughes, Guozhang Xu, Steven K Wetter, et al.
Biochemistry|May 4, 2005
Two photoaffinity analogues of the tripeptide, hemiasterlin, exclusively label alpha-tubulinMaria Nunes, Joshua Kaplan, Joseph Wooters, et al.
Molecular Cancer Therapeutics|October 16, 2004
Cells resistant to HTI-286 do not overexpress P-glycoprotein but have reduced drug accumulation and a point mutation in alpha-tubulinFrank Loganzo, Malathi Hari, Tami Annable, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2007
Synthesis and evaluation of pyrazolo[3,4-b]pyridine CDK1 inhibitors as anti-tumor agentsRonghui Lin, Peter J Connolly, Yanhua Lu, et al.
Seminars in Hematology|April 26, 2023
Report of consensus panel 5 from the 11th international workshop on Waldenstrom's macroglobulinemia on COVID-19 prophylaxis and managementE Terpos, A R Branagan, R García-Sanz, et al.
Molecular Cancer Therapeutics|October 27, 2011
Reduced expression of the androgen receptor by third generation of antisense shows antitumor activity in models of prostate cancerYixian Zhang, Stephen Castaneda, Melissa Dumble, et al.
Journal of Medicinal Chemistry|August 10, 2001
6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinases with enhanced antitumor activityH R Tsou, N Mamuya, B D Johnson, et al.
Biochemical Pharmacology|March 23, 1999
Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with in vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785)C M Discafani, M L Carroll, M B Floyd, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Oncology Research|January 1, 1994
P-glycoprotein mediates profound resistance to bisantreneX P Zhang, M K Ritke, J C Yalowich, et al.
Blood Cancer Discovery|September 8, 2022
Anti-spike T-cell and Antibody Responses to SARS-CoV-2 mRNA Vaccines in Patients with Hematologic MalignanciesLee M Greenberger, Larry A Saltzman, Lore M Gruenbaum, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2008
A novel 5-[1,3,4-oxadiazol-2-yl]-N-aryl-4,6-pyrimidine diamine having dual EGFR/HER2 kinase activity: design, synthesis, and biological activityTerry V Hughes, Guozhang Xu, Steven K Wetter, et al.
Biochemistry|May 4, 2005
Two photoaffinity analogues of the tripeptide, hemiasterlin, exclusively label alpha-tubulinMaria Nunes, Joshua Kaplan, Joseph Wooters, et al.
Molecular Cancer Therapeutics|October 16, 2004
Cells resistant to HTI-286 do not overexpress P-glycoprotein but have reduced drug accumulation and a point mutation in alpha-tubulinFrank Loganzo, Malathi Hari, Tami Annable, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2007
Synthesis and evaluation of pyrazolo[3,4-b]pyridine CDK1 inhibitors as anti-tumor agentsRonghui Lin, Peter J Connolly, Yanhua Lu, et al.
Seminars in Hematology|April 26, 2023
Report of consensus panel 5 from the 11th international workshop on Waldenstrom's macroglobulinemia on COVID-19 prophylaxis and managementE Terpos, A R Branagan, R García-Sanz, et al.
Molecular Cancer Therapeutics|October 27, 2011
Reduced expression of the androgen receptor by third generation of antisense shows antitumor activity in models of prostate cancerYixian Zhang, Stephen Castaneda, Melissa Dumble, et al.
Journal of Medicinal Chemistry|August 10, 2001
6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinases with enhanced antitumor activityH R Tsou, N Mamuya, B D Johnson, et al.
Biochemical Pharmacology|March 23, 1999
Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with in vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785)C M Discafani, M L Carroll, M B Floyd, et al.
Pageof 10